Charles River Laboratories International (CRL) Enterprise Value (2009 - 2025)

Charles River Laboratories International (CRL) has reported Enterprise Value for 17 consecutive years, with -$208.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Enterprise Value fell 35.83% year-over-year to -$208.5 million; the TTM figure through Dec 2025 stood at -$208.5 million (down 35.83% YoY), while the FY2025 annual figure was -$208.5 million, down 35.83% from the prior year.
• Enterprise Value came in at -$208.5 million for Q4 2025 at Charles River Laboratories International, down from -$166.6 million in the prior quarter.
• The five-year high for Enterprise Value was -$117.2 million in Q3 2023, with the low at -$437.4 million in Q1 2021.
• Average Enterprise Value over 5 years is -$191.4 million, with a median of -$177.8 million recorded in 2022.
• Across the five-year window, Enterprise Value jumped 57.46% in 2022 and tumbled 69.72% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$188.2 million in 2021, then slipped by 1.74% to -$191.5 million in 2022, then retreated by 14.92% to -$220.0 million in 2023, then surged by 30.25% to -$153.5 million in 2024, then plunged by 35.83% to -$208.5 million in 2025.
• According to Business Quant data, Enterprise Value over the past three periods registered -$208.5 million, -$166.6 million, and -$142.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.